| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.09B | +4.1% |
| Cost of Revenue | $565.2M | +4.0% |
| R&D Expense | $137.9M | +2.4% |
| SG&A Expense | $238.0M | +10.9% |
| Operating Income | $78.7M | -36.6% |
| Pre-tax Income | $60.8M | -39.8% |
| Income Tax | $16.7M | -41.6% |
| Net Income | $44.1M | -39.1% |
| EPS (Basic) | $1.42 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $150.4M | -26.9% |
| Short-term Investments | $71K | -99.7% |
| Accounts Receivable | $274.2M | +12.2% |
| Current Assets | $766.0M | +2.4% |
| Total Assets | $1.35B | -2.8% |
| Current Liabilities | $527.2M | -24.2% |
| Long-term Debt | $413.0M | +10.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $63.6M | -54.6% |
| Capital Expenditures | $37.0M | +39.3% |
| Investing Cash Flow | -$9.0M | +86.5% |
| Financing Cash Flow | -$51.7M | -54.8% |
| Free Cash Flow | $26.6M | -76.6% |
| -37.7% |
| EPS (Diluted) | $1.41 | -37.6% |
| Total Liabilities |
| $993.3M |
| +4.9% |
| Stockholders' Equity | $355.2M | -18.6% |